Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update comparing several drugs to identify which is most effective against Cutaneous Leishmaniasis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Cutaneous Leihmaniasis | Phase 3 | Status: NOT_YET_RECRUITING